Form 4: Labcorp Executive Sells 1,000 Shares of Common Stock

Labcorp's Executive Vice President and Chief Legal Officer, Sandra D. van der Vaart, sold 1,000 shares of common stock on November 21, 2024.

Summary

• Sandra D. van der Vaart, Executive Vice President and Chief Legal Officer at Labcorp, sold 1,000 shares of the company's common stock on November 21, 2024.
• The sale was executed at a price of $239.4187 per share.
• Following the transaction, Ms. van der Vaart directly owns 2,669.847 shares of Labcorp common stock.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing for an insider stock sale, which is neither positive nor negative in itself. It's a neutral event.

Industry Context

This is a routine SEC Form 4 filing, which is common when company insiders trade shares. It provides transparency into the transactions of company executives.

Comparison to Industry Standards

• Executive stock sales are a common occurrence in publicly traded companies, and this transaction is within the normal range of such activities.
• Other companies in the healthcare sector, such as Quest Diagnostics (DGX) and Charles River Laboratories (CRL), also have executives who regularly file Form 4s for similar transactions.

Stakeholder Impact

• The sale of shares by an executive may have a minor impact on investor sentiment, but it is generally not a significant event unless part of a larger trend.

Key Dates

Keywords

Labcorp, insider trading, stock sale, executive, Sandra D. van der Vaart, common stock, SEC Form 4